Literature DB >> 16216428

Endogenous neuropeptide Y depresses the afferent signaling of gastric acid challenge to the mouse brainstem via neuropeptide Y type Y2 and Y4 receptors.

T Wultsch1, E Painsipp, C K Thoeringer, H Herzog, G Sperk, P Holzer.   

Abstract

Vagal afferents signal gastric acid challenge to the nucleus tractus solitarii of the rat brainstem. This study investigated whether nucleus tractus solitarii neurons in the mouse also respond to gastric acid challenge and whether this chemonociceptive input is modified by neuropeptide Y acting via neuropeptide Y receptors of type Y2 or Y4. The gastric mucosa of female mice was exposed to different concentrations of HCl or saline, excitation of neurons in the nucleus tractus solitarii visualized by c-Fos immunohistochemistry, gastric emptying deduced from the gastric volume recovery, and gastric lesion formation evaluated by planimetry. Relative to saline, intragastric HCl (0.15-0.35 M) increased the number of c-Fos-expressing cells in the nucleus tractus solitarii in a concentration-dependent manner, inhibited gastric emptying but failed to cause significant hemorrhagic injury in the stomach. Mice in which the Y2 or Y4 receptor gene had been deleted responded to gastric acid challenge with a significantly higher expression of c-Fos in the nucleus tractus solitarii, the increases amounting to 39 and 31%, respectively. The HCl-induced inhibition of gastric emptying was not altered by deletion of the Y2 or Y4 receptor gene. BIIE0246 ((S)-N2-[[1-[2-[4-[(R,S)-5,11-dihydro-6(6H)-oxodibenz[b,e] azepin-11-yl]-1-piperazinyl]-2-oxoethyl]cyclopentyl] acetyl]-N-[2-[1,2-dihydro-3,5 (4H)-dioxo-1,2-diphenyl-3H-1,2,4-triazol-4-yl]ethyl]-argininamide; 0.03 mmol/kg s.c.), a Y2 receptor antagonist which does not cross the blood-brain barrier, did not modify the c-Fos response to gastric acid challenge. The Y2 receptor agonist peptide YY-(3-36) (0.1 mg/kg intraperitoneally) likewise failed to alter the gastric HCl-evoked expression of c-Fos in the nucleus tractus solitarii. BIIE0246, however, prevented the effect of peptide YY-(3-36) to inhibit gastric acid secretion as deduced from measurement of intragastric pH. The current data indicate that gastric challenge with acid concentrations that do not induce overt injury but inhibit gastric emptying is signaled to the mouse nucleus tractus solitarii. Endogenous neuropeptide Y acting via Y2 and Y4 receptors depresses the afferent input to the nucleus tractus solitarii by a presumably central site of action.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16216428      PMCID: PMC4359901          DOI: 10.1016/j.neuroscience.2005.08.038

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  61 in total

1.  Duodenal acid-induced gastric relaxation is mediated by multiple pathways.

Authors:  Y X Lu; C Owyang
Journal:  Am J Physiol       Date:  1999-06

2.  Regional distribution of Y-receptor subtype mRNAs in rat brain.

Authors:  R M Parker; H Herzog
Journal:  Eur J Neurosci       Date:  1999-04       Impact factor: 3.386

3.  Cardiac function in neuropeptide Y Y4 receptor-knockout mice.

Authors:  Margaret A Smith-White; Herbert Herzog; Erica K Potter
Journal:  Regul Pept       Date:  2002-12-31

4.  PYY-preferring receptor in the dorsal vagal complex and its involvement in PYY stimulation of gastric acid secretion in rats.

Authors:  H Yang; W P Li; J R Reeve; J Rivier; Y Taché
Journal:  Br J Pharmacol       Date:  1998-04       Impact factor: 8.739

5.  PYY and NPY: control of gastric motility via action on Y1 and Y2 receptors in the DVC.

Authors:  C H Chen; R L Stephens; R C Rogers
Journal:  Neurogastroenterol Motil       Date:  1997-06       Impact factor: 3.598

6.  Acid challenge delays gastric pressure adaptation, blocks gastric emptying and stimulates gastric fluid secretion in the rat.

Authors:  P Holzer; E Painsipp; M Jocic; A Heinemann
Journal:  Neurogastroenterol Motil       Date:  2003-02       Impact factor: 3.598

7.  Gut hormone PYY(3-36) physiologically inhibits food intake.

Authors:  Rachel L Batterham; Michael A Cowley; Caroline J Small; Herbert Herzog; Mark A Cohen; Catherine L Dakin; Alison M Wren; Audrey E Brynes; Malcolm J Low; Mohammad A Ghatei; Roger D Cone; Stephen R Bloom
Journal:  Nature       Date:  2002-08-08       Impact factor: 49.962

8.  Stomach-brain communication by vagal afferents in response to luminal acid backdiffusion, gastrin, and gastric acid secretion.

Authors:  Marion Danzer; Milana Jocic; Claudia Samberger; Evelin Painsipp; Elisabeth Bock; Maria-Anna Pabst; Karl Crailsheim; Rudolf Schicho; Irmgard T Lippe; Peter Holzer
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2003-10-30       Impact factor: 4.052

9.  Reduced anxiety and improved stress coping ability in mice lacking NPY-Y2 receptors.

Authors:  Alexandra Tschenett; Nicolas Singewald; Mirjana Carli; Claudia Balducci; Peter Salchner; Annamaria Vezzani; Herbert Herzog; Günther Sperk
Journal:  Eur J Neurosci       Date:  2003-07       Impact factor: 3.386

10.  Species differences in the expression and distribution of the neuropeptide Y Y1, Y2, Y4, and Y5 receptors in rodents, guinea pig, and primates brains.

Authors:  Y Dumont; D Jacques; P Bouchard; R Quirion
Journal:  J Comp Neurol       Date:  1998-12-21       Impact factor: 3.215

View more
  10 in total

1.  Chemo-nociceptive signalling from the colon is enhanced by mild colitis and blocked by inhibition of transient receptor potential ankyrin 1 channels.

Authors:  Martina Mitrovic; Anaid Shahbazian; Elisabeth Bock; Maria A Pabst; Peter Holzer
Journal:  Br J Pharmacol       Date:  2010-07       Impact factor: 8.739

2.  Peptide Tyrosine Tyrosine 3-36 Reduces Meal Size and Activates the Enteric Neurons in Male Sprague-Dawley Rats.

Authors:  Kayla D Newman; Thaer R Mhalhal; Martha C Washington; John C Heath; Ayman I Sayegh
Journal:  Dig Dis Sci       Date:  2017-10-13       Impact factor: 3.199

3.  Peripheral peptide YY inhibits propulsive colonic motor function through Y2 receptor in conscious mice.

Authors:  Lixin Wang; Guillaume Gourcerol; Pu-Qing Yuan; S Vincent Wu; Mulugeta Million; Muriel Larauche; Yvette Taché
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-11-05       Impact factor: 4.052

4.  Sex-dependent control of murine emotional-affective behaviour in health and colitis by peptide YY and neuropeptide Y.

Authors:  Evelin Painsipp; Herbert Herzog; Günther Sperk; Peter Holzer
Journal:  Br J Pharmacol       Date:  2011-07       Impact factor: 8.739

5.  Increase in gastric acid-induced afferent input to the brainstem in mice with gastritis.

Authors:  P Holzer; T Wultsch; M Edelsbrunner; M Mitrovic; A Shahbazian; E Painsipp; E Bock; M A Pabst
Journal:  Neuroscience       Date:  2007-02-14       Impact factor: 3.590

6.  Selective increase of dark phase water intake in neuropeptide-Y Y2 and Y4 receptor knockout mice.

Authors:  Thomas Wultsch; Evelin Painsipp; Sabine Donner; Günther Sperk; Herbert Herzog; Bernhard A Peskar; Peter Holzer
Journal:  Behav Brain Res       Date:  2005-12-20       Impact factor: 3.332

Review 7.  Neuropeptide Y, peptide YY and pancreatic polypeptide in the gut-brain axis.

Authors:  Peter Holzer; Florian Reichmann; Aitak Farzi
Journal:  Neuropeptides       Date:  2012-09-11       Impact factor: 3.286

8.  Visceral hyperalgesia caused by peptide YY deletion and Y2 receptor antagonism.

Authors:  Ahmed M Hassan; Piyush Jain; Raphaela Mayerhofer; Esther E Fröhlich; Aitak Farzi; Florian Reichmann; Herbert Herzog; Peter Holzer
Journal:  Sci Rep       Date:  2017-01-20       Impact factor: 4.379

Review 9.  Neuropeptides and the microbiota-gut-brain axis.

Authors:  Peter Holzer; Aitak Farzi
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

10.  Deletion of the acid-sensing ion channel ASIC3 prevents gastritis-induced acid hyperresponsiveness of the stomach-brainstem axis.

Authors:  Thomas Wultsch; Evelin Painsipp; Anaid Shahbazian; Martina Mitrovic; Martin Edelsbrunner; Michel Lazdunski; Rainer Waldmann; Peter Holzer
Journal:  Pain       Date:  2007-05-24       Impact factor: 7.926

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.